Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

FLEXION THERAPEUTICS, INC.

(FLXN)
OverzichtKoersenGrafiekenNieuwsRatingsOndernemingFinanciŽnBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Communiquťs de presse de la sociťtť FLEXION THERAPEUTICS, INC.
2021FLEXION THERAPEUTICS INC : Entry into a Material Definitive Agreement, Termination of a Ma..
AQ
2021FLEXION THERAPEUTICS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION A..
AQ
2021SHAREHOLDER ALERT : Monteverde & Associates PC Announces an Investigation of Flexion Thera..
PR
2021SHAREHOLDER ALERT : WeissLaw LLP Reminds ADMS, FLXN, AZPN, and EBMT Shareholders About Its..
PR
2021SHAREHOLDER ALERT : WeissLaw LLP Reminds ADMS, FLXN, AZPN, and EBMT Shareholders About Its..
PR
2021FLEXION THERAPEUTICS INVESTOR ALERT : Kahn Swick & Foti, LLC Investigates Adequacy of Pri..
BU
2021FLEXION THERAPEUTICS INC : Entry into a Material Definitive Agreement, Results of Operatio..
AQ
2021SHAREHOLDER ALERT : Ademi LLP investigates whether Flexion Therapeutics, Inc. has obtained..
PR
2021FLEXION MERGER INVESTIGATION : Halper Sadeh LLP Announces Investigation Into Whether the S..
BU
2021FLEXION THERAPEUTICS : Reports Inducement Grants Under†Nasdaq Listing Rule 5635(c)(4)
GL
2021Flexion Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Co..
GL
2021FLEXION THERAPEUTICS : to Present at the Wells Fargo 2021 Virtual Healthcare Conference
AQ
2021FLEXION THERAPEUTICS : Announces Inclusion of ZILRETTA in American Academy of Orthopaedic ..
AQ
2021Flexion Therapeutics to Present at the Wells Fargo 2021 Virtual Healthcare Conference
GL
2021FLEXION THERAPEUTICS : Announces Inclusion of ZILRETTAģ in American Academy of Orthopaedic..
AQ
2021FLEXION THERAPEUTICS : Announces Expansion of Phase 1b Trial Investigating FX301 for the M..
AQ
2021FLEXION THERAPEUTICS : Announces Publication of Results from Phase 2 Pharmacokinetics (PK)..
AQ
2021FLEXION THERAPEUTICS : Q2 2021 Commercial Metrics Overview - August 4, 2021
PU
2021FLEXION THERAPEUTICS : Reports Second-Quarter 2021 Financial Results and Recent Business H..
PU
2021FLEXION THERAPEUTICS : Q2 Earnings Snapshot
AQ
2021FLEXION THERAPEUTICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RES..
AQ
2021FLEXION THERAPEUTICS : Reports Second-Quarter 2021 Financial Results†and Recent Business H..
AQ
2021FLEXION THERAPEUTICS : to Report Second-Quarter 2021 Financial Results on August 4, 2021
AQ
2021FLEXION THERAPEUTICS INC : Change in Directors or Principal Officers (form 8-K)
AQ
2021Flexion Therapeutics Announces Appointment of Utpal Koppikar to its Board of Directors
GL
2021FLEXION THERAPEUTICS : Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)
AQ
2021Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
2021FLEXION THERAPEUTICS INC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
2021FLEXION THERAPEUTICS : Q1 Earnings Snapshot
AQ
2021Flexion Therapeutics to Present at the 2021 Raymond James Human Health Innovation Confe..
GL
2021Flexion Therapeutics Announces Appointment of William T. Andrews, M.D., F.A.C.P., as Ch..
GL
2021FLEXION THERAPEUTICS : Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)
AQ
2021Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
2021Flexion Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Virt..
GL
2021FLEXION THERAPEUTICS : Reports First-Quarter 2021 Financial Results and Recent Business Up..
PU
2021Flexion Therapeutics to Present at the RBC Capital Markets 2021 Virtual Global Healthca..
GL
2021FLEXION THERAPEUTICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RES..
AQ
2021FLEXION THERAPEUTICS INC : Results of Operations and Financial Condition, Change in Direct..
AQ
2021Flexion Therapeutics Reports First-Quarter 2021 Financial Results and Recent Business U..
GL
2021FLEXION THERAPEUTICS INC : Regulation FD Disclosure, Financial Statements and Exhibits (fo..
AQ
2021Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
2021Flexion Therapeutics to Report First-Quarter 2021 Financial Results on May 12, 2021
GL
2021Flexion Therapeutics Announces Presentation of Preliminary FX201 Clinical Data at the U..
GL
2021FLEXION THERAPEUTICS : Q1 2021 Commercial Metrics Overview
PU
2021FLEXION THERAPEUTICS INC : Results of Operations and Financial Condition, Other Events, Fi..
AQ
2021Flexion Therapeutics Announces Preliminary First-Quarter 2021 Revenue and Provides Fina..
GL
2021Flexion Therapeutics to Present at the Needham 20th Annual Virtual Healthcare Conferenc..
GL
2021FLEXION THERAPEUTICS INC : Change in Directors or Principal Officers (form 8-K)
AQ
2021FLEXION THERAPEUTICS : Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)
AQ
2021Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
2021Flexion Therapeutics Announces First Patient Treated in FX301 Phase 1b Trial for Manage..
GL
2021Flexion Therapeutics to Present at the Oppenheimer 31st Annual Virtual Healthcare Confe..
GL
2021FLEXION THERAPEUTICS : Q4 Earnings Snapshot
AQ
2021FLEXION THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Res..
AQ
2021FLEXION THERAPEUTICS INC : Results of Operations and Financial Condition, Change in Direct..
AQ
2021Flexion Therapeutics Reports Fourth-Quarter and Full-Year 2020 Financial Results
GL
2021FLEXION THERAPEUTICS : Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
2021Flexion Therapeutics to Report Fourth-Quarter and Full-Year 2020 Financial Results on M..
GL
2021FLEXION THERAPEUTICS : Announces FDA Clearance of Investigational New Drug Application for..
AQ
2021Flexion Therapeutics to Present at the 42nd Annual Raymond James Virtual Institutional ..
GL
2021FLEXION THERAPEUTICS : to Advance Investigational Gene Therapy FX201 into High Dose Cohort..
AQ
2021National Basketball Retired Players Association, Sheryl Swoopes and Flexion Therapeutic..
GL
2021FLEXION THERAPEUTICS : Q4 2020 Commercial Metrics Overview
PU
2021FLEXION THERAPEUTICS INC : Results of Operations and Financial Condition, Other Events, Fi..
AQ
2021Flexion Therapeutics Announces Preliminary, Unaudited Fourth-Quarter and Full-Year 2020..
GL
2021Flexion Therapeutics to Present at the ICR | Westwicke Investment Conference
GL
2020FLEXION THERAPEUTICS : to Present at the Needham Virtual Epilepsy and Pain Specialty CNS T..
AQ
2020Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
2020FLEXION THERAPEUTICS INC : Results of Operations and Financial Condition (form 8-K)
AQ
2020FLEXION THERAPEUTICS : Reports Inducement Grants under Nasdaq Listing Rule 5635
AQ
2020FLEXION THERAPEUTICS : Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
2020Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GL
2020FLEXION THERAPEUTICS : to Present at the 29th Annual Credit Suisse Virtual Healthcare Conf..
AQ
2020Flexion Therapeutics to Present at the 29th Annual Credit Suisse Virtual Healthcare Con..
GL
2020FLEXION THERAPEUTICS : 3Q Earnings Snapshot
AQ
1  2  3  4  5Volgende